These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12008671)
1. [New therapeutic prospects with capecitabin in breast carcinoma]. Venturini M; Catzeddu T Tumori; 2002; 88(1):A1-6. PubMed ID: 12008671 [No Abstract] [Full Text] [Related]
2. [Tumor specific therapy. Targeted breast cancer therapy]. MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603691 [No Abstract] [Full Text] [Related]
3. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003. Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064 [No Abstract] [Full Text] [Related]
4. [Capecitabine in the treatment of colorectal cancer]. Zeuli M; Pino MS; Cognetti F Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027 [No Abstract] [Full Text] [Related]
6. Moving forward with capecitabine: a glimpse of the future. Biganzoli L; Martin M; Twelves C Oncologist; 2002; 7 Suppl 6():29-35. PubMed ID: 12454317 [TBL] [Abstract][Full Text] [Related]
7. Capecitabine in breast cancer: current status. Smorenburg CH; Bontenbal M; Verweij J Clin Breast Cancer; 2001 Jan; 1(4):288-93; discussion 294. PubMed ID: 11899351 [TBL] [Abstract][Full Text] [Related]
8. Nursing considerations for capecitabine-based combination therapy. Becze E ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236 [No Abstract] [Full Text] [Related]
9. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer. Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E Tumori; 2001; 87(6):364-71. PubMed ID: 11989587 [TBL] [Abstract][Full Text] [Related]
10. Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer. Mader RM; Schrolnberger C; Rizovski B; Brunner M; Wenzel C; Locker G; Eichler HG; Mueller M; Steger GG Int J Clin Pharmacol Ther; 2002 Dec; 40(12):571-2. PubMed ID: 12503818 [No Abstract] [Full Text] [Related]
11. [Oral fluoropyrimidines in the treatment of colorectal carcinoma]. Porschen R Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344 [No Abstract] [Full Text] [Related]
12. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same. Mayer RJ J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576 [No Abstract] [Full Text] [Related]
14. Coronary spasm induced by capecitabine. Schnetzler B; Popova N; Collao Lamb C; Sappino AP Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636 [No Abstract] [Full Text] [Related]
15. Targeted therapy for metastatic breast cancer. Muss HB N Engl J Med; 2006 Dec; 355(26):2783-5. PubMed ID: 17192546 [No Abstract] [Full Text] [Related]
16. [Capecitabine in colorectal carcinoma: news from ASCO 2008]]. Longo F; Mansueto G Tumori; 2008; 94(4):suppl 15-23. PubMed ID: 18822712 [No Abstract] [Full Text] [Related]
17. [Oral capecitabine therapy: experience and developments at the Milano Cancer Institute]. Longo F; Mansueto G Tumori; 2004; 90(1):suppl 17-27. PubMed ID: 15143996 [No Abstract] [Full Text] [Related]
18. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer. Aprile G; Mazzer M; Moroso S; Puglisi F Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178 [TBL] [Abstract][Full Text] [Related]
19. Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. Wang ML; Yung WK; Royce ME; Schomer DF; Theriault RL Am J Clin Oncol; 2001 Aug; 24(4):421-4. PubMed ID: 11474279 [TBL] [Abstract][Full Text] [Related]
20. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Yoon-Koo Kang. Kang YK Drugs; 2007; 67(4):611-2. PubMed ID: 17352520 [No Abstract] [Full Text] [Related] [Next] [New Search]